WW
ABBV icon

Windle Wealth’s AbbVie ABBV Stock Holding History

Windle Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.31M Buy
42,788
+1,463
+4% +$325K 3.93% 13
2025
Q4 		$9.44M Sell
41,325
-1,749
-4% -$398K 4.23% 6
2025
Q3 		$9.97M Buy
43,074
+386
+0.9% +$78.6K 4.46% 5
2025
Q2 		$7.92M Sell
42,688
-135
-0.3% -$25.1K 3.87% 11
2025
Q1 		$8.97M Buy
42,823
+1,801
+4% +$350K 4.62% 3
2024
Q4 		$7.29M Buy
41,022
+1,854
+5% +$341K 4.03% 10
2024
Q3 		$7.73M Buy
39,168
+792
+2% +$148K 4.2% 10
2024
Q2 		$6.58M Sell
38,376
-606
-2% -$100K 4.01% 13
2024
Q1 		$7.1M Sell
38,982
-1,327
-3% -$229K 4.52% 4
2023
Q4 		$6.25M Sell
40,309
-1,570
-4% -$229K 4.38% 9
2023
Q3 		$6.24M Buy
41,879
+987
+2% +$145K 4.65% 6
2023
Q2 		$5.51M Buy
40,892
+625
+2% +$91.7K 3.98% 16
2023
Q1 		$6.42M Buy
40,267
+747
+2% +$114K 4.76% 4
2022
Q4 		$6.39M Buy
+39,520
New +$6.06M 4.99% 4

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Windle Wealth's ABBV Position: Q1 2026 in Review

Windle Wealth increased its AbbVie (ABBV) stake by 3.5% in Q1 2026, buying an estimated $325K and bringing the position to 42,788 shares worth $9.31M. The position accounts for 3.93% of the portfolio, ranked #13.

Windle Wealth first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.97M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Windle Wealth held 42,788 shares of AbbVie worth $9.31M as of Q1 2026.
  • Windle Wealth bought 1,463 AbbVie shares in Q1 2026, an estimated $325K.
  • AbbVie made up 3.93% of Windle Wealth's portfolio in Q1 2026, its #13 holding.
  • Windle Wealth first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • Windle Wealth's AbbVie position peaked at $9.97M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Windle Wealth's 13F filing for Q1 2026, filed 11 May 2026.